Mevalonic acid

Mevalonic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Mevalonic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Mevalonic acid

MeSH term MeSH ID Detail
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 | Total 25

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Mevalonic acid

Download all related citations
Per page 10 20 50 100 | Total 2899
Authors Title Published Journal PubMed Link
Hosaka A et al. Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons. 2013 Neurochem. Res. pmid:23269484
Qi XF et al. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway. 2013 Cell Death Dis pmid:23449454
Zhang J et al. Statins directly suppress cytokine production in murine intraepithelial lymphocytes. 2013 Cytokine pmid:23290865
Rauthan M et al. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23530189
Liu J et al. Overproduction of geraniol by enhanced precursor supply in Saccharomyces cerevisiae. 2013 J. Biotechnol. pmid:24161921
Valente AJ et al. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. 2013 Cell. Signal. pmid:23541442
Chen B et al. Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction. 2013 Cell. Physiol. Biochem. pmid:24356578
Dellas N et al. Discovery of a metabolic alternative to the classical mevalonate pathway. 2013 Elife pmid:24327557
Corcos L and Le Jossic-Corcos C Statins: perspectives in cancer therapeutics. 2013 Dig Liver Dis pmid:23490341
Lesma E et al. Chromatin remodeling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin. 2013 J. Pharmacol. Exp. Ther. pmid:23426956